1.
Open Forum Infect Dis
; 10(4): ofad189, 2023 Apr.
Article
in English
| MEDLINE | ID: covidwho-2292576
ABSTRACT
Immunocompromised patients with B-cell deficiencies are at risk for prolonged symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We describe 4 patients treated for B-cell malignancies with B-cell-depleting therapies who developed persistent SARS-CoV-2 infection and had resolution of symptoms following an extended course of nirmatrelvir/ritonavir.
2.
JAMA Intern Med
; 182(9): 999-1000, 2022 09 01.
Article
in English
| MEDLINE | ID: covidwho-2027260